BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31750584)

  • 1. Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis.
    Miguel AFP; Mello FW; Melo G; Rivero ERC
    Head Neck; 2020 Mar; 42(3):569-584. PubMed ID: 31750584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
    Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
    Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Expression Of ADAM 10 as a Predictor of Lymph Node Metastasis in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
    Jain R; Gosavi S; Sethia D; Trimuke A; Salunke M
    Head Neck Pathol; 2022 Dec; 16(4):1055-1062. PubMed ID: 35771404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
    Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma.
    Myoung H; Kim MJ; Hong SD; Lee JI; Lim CY; Hong SP
    Cancer Lett; 2002 Nov; 185(2):201-9. PubMed ID: 12169394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes].
    Liu G; Li J; Li Z; Chen X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):216-8, 224. PubMed ID: 12539723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
    Xie M; Sun Y; Li Y
    Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
    Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
    Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
    Erdem NF; Carlson ER; Gerard DA; Ichiki AT
    J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma.
    Kim JM; Kim HJ; Koo BS; Rha KS; Yoon YH
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):1137-42. PubMed ID: 22907031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth.
    Kawano K; Yanagisawa S
    Head Neck; 2006 Jun; 28(6):525-33. PubMed ID: 16619276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas].
    Liu LK; Li YN; Jiang HB; He ZX; Yi XZ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological significance of podoplanin immunoexpression in oral and oropharyngeal squamous cell carcinoma: A systematic review.
    Mello FW; Kammer PV; Silva CAB; Parkinson EK; Monteiro L; Warnakulasuriya S; Rivero ERC
    J Oral Pathol Med; 2021 Jan; 50(1):1-9. PubMed ID: 32449167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
    Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.